Navigation Links
EPO Effective For Cancer Patients Suffering From Anemia

According to the third phase of clinical trail conducted by researchers at St. Jude Children's Research Hospital it was found that a weekly dose of erythropoietin //(EPO) is a very effective treatment for children suffering from cancer who develop anemia during chemotherapy.

EPO is a natural hormone that stimulates production of hemoglobin. It reduces the need for red blood cell (RBC) transfusions in these children. This is the first large-scale study of anemic children with cancer that randomly assigned patients to receive either EPO or a placebo (inactive ‘drug’) intravenously, and the first to measure the effect of EPO on quality of life in children, according to Bassem Razzouk, M.D., an associate member of the Department of Oncology at St. Jude.

Razzouk is the lead author of a report on this study that appears in the August 1 issue of the Journal of Clinical Oncology. ‘EPO was already known to benefit adults with cancer by increasing their hemoglobin level and improving their quality of life,’ Razzouk said. ‘But even though many children with cancer are anemic, there has been little evidence to support the use of EPO in such children who are receiving chemotherapy.’

Chemotherapy can suppress the production of red blood cells and cause anemia. ‘Our study showed that EPO not only improves the child's condition, but is also well tolerated, which makes it more acceptable to the patient,’ he added. The study was also significant because a smaller clinical trial at another institution included three subcutaneous injections per week of EPO, while children in the current study received EPO only once a week intravenously. ‘Our use of intravenous administration of EPO instead of subcutaneous injections reduced the suffering of children and allowed us to complete a major clinical trial that demonstrated the effectiveness of this treatment,’ Razzouk said.

The study, which was led by St. Jude, was conducted at 26 sites in the United States and included anemic patients 5 to 18 years of age who were receiving chemotherapy for solid tumors (excluding brain tumors), lymphoma and leukemia. A total of 111 patients received EPO and 111 received a placebo. The researchers studied the effect of EPO treatment on quality of life using a test called the Pediatric Quality of Life InventoryTM 4.0 Generic Core Scales (PedsQLTM-GCS), a survey that includes questions on physical, emotional and social functioning as well as school performance. The team concluded that EPO increases Hb levels in children with anemia, reduces their need for transfusions and improves the quality of life in those who have an increase in Hb.

Source: Euekalert

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Inhaled Steroids Safe & Effective for Children with Asthma
3. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
4. Fluoride Found Effective in Osteoporosis
5. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
6. Implantable Contact Lens Found Safe and Effective
7. Effective And Economical Agent For Anthrax
8. Stem Cell Transplants May Be Effective For MS Patients
9. Effective therapy for Huntingtons disease
10. Chemotherapy Effective for Bladder Cancer
11. Drug Effective for Vascular Dementia
Post Your Comments:

(Date:11/30/2015)... ... 2015 , ... Third Molar SEO , one of ... launched a sleek, mobile-ready and user-centric redesigned website. , Vivek Srivastava, founder and ... the benefits that its SEO services provide to dentists and why Third Molar ...
(Date:11/30/2015)... ... 01, 2015 , ... The National Association of Professional Women (NAPW) ... the Year Circle. She is recognized with this prestigious distinction for leadership in estate ... boasting more than 850,000 members and over 200 operating Local Chapters. , “I’m pleased ...
(Date:11/30/2015)... ... November 30, 2015 , ... Until now, the St. Louis Fetal ... MOMS (Management of Myelomeningocele Study) trial. One of these exclusion criteria was a BMI ... of 18.5 to 24.9 is considered normal, 25 - 29.9 is overweight and above ...
(Date:11/30/2015)... ... November 30, 2015 , ... An extensive ... is specialized and only includes chiropractic clinics in the US. , The team ... alternative health practitioner when back pain sets in. When people are experiencing back ...
(Date:11/30/2015)... ... November 30, 2015 , ... On Saturday, October 24th, 2015, at the ... annual fundraising event, a 5K walk known as “Making Strides Against Breast Cancer”. Patients ... which is also located in Battle Creek, joined in for this campaign that sought ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... 30, 2015  QT Vascular Ltd., together with its ... its subsidiaries, TriReme Medical LLC and Quattro Vascular Pte. ... the design, assembly and distribution of advanced therapeutic solutions ... pleased to announce that a three-judge panel of ... for the Federal Circuit ("Federal Circuit") has unanimously granted ...
(Date:11/30/2015)... 30, 2015   Royal Philips  (NYSE: ... of Radiology Solutions, a fully integrated, consultative approach ... customized, data-driven practice management approaches that combine imaging ... practices improve care delivery and reduce costs. Making ... of North America Annual Meeting (RSNA) in ...
(Date:11/30/2015)... Nautilus Medical Inc. today announced worldwide availability of MatrixRay, ... The release of MatrixRay to the entire medical healthcare ... America) in Chicago - the ... --> --> MatrixRay is the first ... worldwide via a peer-to-peer exchange network of physicians and ...
Breaking Medicine Technology: